vimarsana.com

Page 7 - அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் இதயம் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Flashy Results From Double Valve Switch Surgery for AVR Candidates

email article In experienced hands, the Ross procedure was associated with favorable short- and long-term outcomes in young patients requiring aortic valve replacement (AVR), according to a retrospective cohort study. Survival was 95.1% at 10 years 88.5% at 15 years among more than 1,400 adults undergoing the double-valve procedure at highly specialized centers, Mostafa Mokhles, MD, PhD, of Utrecht University Medical Center in The Netherlands, and colleagues reported. The Ross procedure continues to be the only living-valve alternative in young and middle-aged patients with a reported survival that compares with the general population well into the second postoperative decade, the group wrote in

Low-Risk TAVR at 2 Years: Thrombosis Concerns Creep In

P=0.046) The TAVR group had had more deaths and strokes between 1 and 2 years compared with the SAVR group, according to the PARTNER 3 investigators led by Martin Leon, MD, of Columbia University Irving Medical Center in New York City. Their report was published in the March 9 issue of the Clearly, ongoing assessment of clinical and echocardiographic findings is needed in younger and low-risk patients and planned follow-up in PARTNER 3 will continue through at least 10 years, Leon and colleagues wrote. The convergence in death and stroke came as no surprise to cardiac surgeon Joseph Bavaria, MD, of the Hospital of the University of Pennsylvania in Philadelphia, who participated in the trial.

New guidelines aims to help reduce blood pressure for chronic kidney disease patients

New guidelines aim to help reduce blood pressure for chronic kidney disease patients A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health. The new recommendation from Kidney Disease: Improving Global Outcomes, a global nonprofit that develops evidence-based clinical practice guidelines in kidney disease, is aimed at doctors to help them to reduce blood pressure for chronic kidney disease patients whose systolic blood pressure levels are over 120 mmHg. Blood pressure can be reduced using antihypertensive medications and lifestyle modifications. The analysis indicates that 69.5 percent of chronic kidney disease patients in the United States a total of 24.5 million people would meet that criterion.

Health guidelines could benefit 25 million Americans with chronic kidney disease

Health guidelines could benefit 25 million Americans with chronic kidney disease New guidelines call for bringing blood pressure levels down to 120 mmHg systolic in chronic kidney disease patients Credit: Getty Images Feb 24, 2021 A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health. The new recommendation published by Kidney Disease: Improving Global Outcomes, a global nonprofit that develops evidence-based clinical practice guidelines in kidney disease is aimed at doctors to help them to reduce blood pressure for chronic kidney disease patients whose systolic blood pressure levels are over 120 mmHg. Blood pressure can be reduced using antihypertensive medications and lifestyle modifications. The analysis indicates

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.